Abstract
Purpose
Gastritis caused by infection with Helicobacter pylori is characterized by chronic inflammation and damage in gastric tissue, which is a main risk factor for gastric cancer. Associated with H. pylori, the TP53 gene tumor suppressor and the cell adhesion glycoprotein epithelial cadherin develop a relevant role in the integrity and carcinogenesis of the epithelium. We aimed to detection of H. pylori and its main virulence markers and measured the messenger RNA (mRNA) expression levels of E-cadherin and TP53 genes.
Methods
The detection of H. pylori and its virulence markers, as well as the mRNA expression levels of E-cadherin and TP53 genes, were obtained for 161 samples of gastric biopsies including 37 with normal gastric tissue, 70 with gastritis, 24 from neoplastic tissue, and 27 from adjacent non-neoplastic by means of a quantitative real-time polymerase chain reaction.
Results
The mRNA expression levels of E-cadherin and TP53 were found to be decreased in patients with gastritis, independently of H. pylori infection. In samples from gastric patients, the neoplastic tissue showed an accentuated decrease of expression; on the other hand, the expression of E-cadherin was normal in adjacent non-neoplastic.
Conclusions
No evidence was found of the involvement of the cagA and vacA genes in the decreased expression of E-cadherin and TP53. The process of carcinogenesis is complex, and the decrease of the E-cadherin gene expression and TP53 gene expression appears to contribute significantly.
Similar content being viewed by others
References
Murakami M, Fukuzawa M, Yamamoto M, Hamaya K, Tamura Y, Sugiyama A, et al. Effects of Helicobacter pylori infection on gastric parietal cells and E-cadherin in Mongolian gerbils. J Pharmacol Sci. 2013;121(4):305–11.
Schildberg CW, Abba M, Merkel S, Agaimy A, Dimmler A, Schlabrakowski A, et al. Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populations. Adv Med Sci. 2014;59(1):142–6. doi:10.1016/j.advms.2014.03.002.
Yang YL, Chen MW, Xian L. Prognostic and clinicopathological significance of downregulated e-cadherin expression in patients with Non-Small Cell Lung Cancer (NSCLC): a meta-analysis. PLoS One. 2014;9(6):e99763. doi:10.1371/journal.pone.0099763.
Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta. 1994;1198(1):11–26.
Lazar D, Taban S, Sporea I, Dema A, Cornianu M, Lazar E, et al. The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients. Romanian J Morphol Embryol Rev Roum Morphol Embryol. 2010;51(2):249–57.
Kim JH, Choi YJ, Lee SH, Shin HS, Lee IO, Kim YJ, et al. Effect of Helicobacter pylori infection on the sonic hedgehog signaling pathway in gastric cancer cells. Oncol Rep. 2010;23(6):1523–8.
Santos JC, Ladeira MS, Pedrazzoli Jr J, Ribeiro ML. Relationship of IL-1 and TNF-alpha polymorphisms with Helicobacter pylori in gastric diseases in a Brazilian population. Braz J Med Biol Res / Rev Bras Pesqui Med Biol / Soc Bras Biofisica. 2012;45(9):811–7.
Dong L, Zhu J, Wen X, Jiang T, Chen Y. Involvement of SET in the Wnt signaling pathway and the development of human colorectal cancer. Oncol Lett. 2014;7(4):1203–8. doi:10.3892/ol.2014.1866.
Yu XW, Xu Q, Xu Y, Gong YH, Yuan Y. Expression of the E-cadherin/beta-catenin/tcf-4 pathway in gastric diseases with relation to Helicobacter pylori infection: clinical and pathological implications. Asian Pac J Cancer Prev : APJCP. 2014;15(1):215–20.
Zhu Y, Zhou X, Wu J, Su J, Zhang G. Risk factors and prevalence of helicobacter pylori infection in persistent high incidence area of gastric carcinoma in Yangzhong City. Gastroenterol Res Pract. 2014;2014:481365. doi:10.1155/2014/481365.
Correa P. Human gastric carcinogenesis: a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52(24):6735–40.
Weydig C, Starzinski-Powitz A, Carra G, Lower J, Wessler S. CagA-independent disruption of adherence junction complexes involves E-cadherin shedding and implies multiple steps in Helicobacter pylori pathogenicity. Exp Cell Res. 2007;313(16):3459–71. doi:10.1016/j.yexcr.2007.07.015.
Watanabe T, Asano N, Fichtner-Feigl S, Gorelick PL, Tsuji Y, Matsumoto Y, et al. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J Clin Invest. 2010;120(5):1645–62. doi:10.1172/JCI39481.
Stolte M, Meining A. The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can J Gastroenterol J Can Gastroenterol. 2001;15(9):591–8.
Scholte GH, van Doorn LJ, Quint WG, Lindeman J. Polymerase chain reaction for the detection of Helicobacter pylori in formaldehyde-sublimate fixed, paraffin-embedded gastric biopsies. Diagn Mol Pathol Amer J Sur Pathol B. 1997;6(4):238–43.
Pereira WN, Ferraz MA, Zabaglia LM, de Labio RW, Orcini WO, Ximenez JPB, Neto AC, Payão SLM, Rasmussen L (2014) Association among H. pylori virulence markers dupA, cagA and vacA in Brazilian patients. J Venomous Anim Toxins Incl Trop Dis 20 (1):5
van Doorn LJ, Figueiredo C, Rossau R, Jannes G, van Asbroek M, Sousa JC, et al. Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization. J Clin Microbiol. 1998;36(5):1271–6.
Gomes LI, Rocha GA, Rocha AM, Soares TF, Oliveira CA, Bittencourt PF, et al. Lack of association between Helicobacter pylori infection with dupA-positive strains and gastroduodenal diseases in Brazilian patients. Int J Med Microbiol : IJMM. 2008;298(3–4):223–30. doi:10.1016/j.ijmm.2007.05.006.
Atherton JC, Peek Jr RM, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology. 1997;112(1):92–9.
Rasmussen LT, de Labio RW, Neto AC, Silva LC, Queiroz VF, Smith MAC, et al. Detection of Helicobacter pylori in gastric biopsies, saliva and dental plaques of dyspeptic patients from Marília, São Paulo, Brazil: presence of vacA and cagA genes. J Venomous Anim Toxins Incl Trop Dis. 2012;18(2):7. doi:10.1590/S1678-91992012000200008.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001;25(4):402–8. doi:10.1006/meth.2001.1262.
Hoy B, Lower M, Weydig C, Carra G, Tegtmeyer N, Geppert T, et al. Helicobacter pylori HtrA is a new secreted virulence factor that cleaves E-cadherin to disrupt intercellular adhesion. EMBO Rep. 2010;11(10):798–804. doi:10.1038/embor.2010.114.
Wroblewski LE, Shen L, Ogden S, Romero-Gallo J, Lapierre LA, Israel DA, et al. Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation. Gastroenterology. 2009;136(1):236–46. doi:10.1053/j.gastro.2008.10.011.
Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene. 2007;26(32):4617–26. doi:10.1038/sj.onc.1210251.
Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest. 2004;113(3):321–33. doi:10.1172/JCI20925.
Peek Jr RM, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol. 2006;208(2):233–48. doi:10.1002/path.1868.
Li T, Chen J, Liu QL, Huo ZH, Wang ZW. Meta-analysis: E-cadherin immunoexpression as a potential prognosis biomarker related to gastric cancer metastasis in Asian patients. Eur Rev Med Pharmacol Sci. 2014;18(18):2693–703.
Liu Y, Chen XG, Liang CZ. Expressions of E-cadherin and N-cadherin in prostate cancer and their implications. Zhonghua Nan Ke Xue Natl J Androl. 2014;20(9):781–6.
Mehendiratta M, Solomon MC, Boaz K, Guddattu V, Mohindra A. Clinico-pathological correlation of E-cadherin expression at the invasive tumor front of Indian oral squamous cell carcinomas: an immunohistochemical study. J Oral Maxillofac Pathol : JOMFP. 2014;18(2):217–22. doi:10.4103/0973-029X.140753.
Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology. 2008;135(6):2128–40. doi:10.1053/j.gastro.2008.07.027. 2140 e2121-2128.
Wu X, Zhuang YX, Hong CQ, Chen JY, You YJ, Zhang F, et al. Clinical importance and therapeutic implication of E-cadherin gene methylation in human ovarian cancer. Med Oncol. 2014;31(8):100. doi:10.1007/s12032-014-0100-y.
Maretzky T, Reiss K, Ludwig A, Buchholz J, Scholz F, Proksch E, et al. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci U S A. 2005;102(26):9182–7. doi:10.1073/pnas.0500918102.
Mayerle J, Schnekenburger J, Kruger B, Kellermann J, Ruthenburger M, Weiss FU, et al. Extracellular cleavage of E-cadherin by leukocyte elastase during acute experimental pancreatitis in rats. Gastroenterology. 2005;129(4):1251–67. doi:10.1053/j.gastro.2005.08.002.
Fujita Y, Krause G, Scheffner M, Zechner D, Leddy HE, Behrens J, et al. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol. 2002;4(3):222–31. doi:10.1038/ncb758.
Wei J, Noto JM, Zaika E, Romero-Gallo J, Piazuelo MB, Schneider B, et al. Bacterial CagA protein induces degradation of p53 protein in a p14ARF-dependent manner. Gut. 2014. doi:10.1136/gutjnl-2014-307295.
Karim S, Ali A. Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India. World J Gastroenterol : WJG. 2009;15(11):1381–7.
Ierardi E, Di Leo A, Barone M, Marangi S, Burattini O, Panarese A, et al. Tumor necrosis factor alpha and apoptosis in Helicobacter pylori related progressive gastric damage: a possible mechanism of immune system involvement in epithelial turnover regulation. Immunopharmacol Immunotoxicol. 2003;25(2):203–11.
Kulak K, Bobinski M, Polak G, Jedrych BJ, Kotarski J, Bednarek W. Expression of caspase 9 and p53 in uterine leiomyosarcomas. Ginekol Pol. 2014;85(8):600–4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interests
The authors declare that there is no conflict of interests.
Funding Information
The authors would like to thank the São Paulo Research Foundation (FAPESP) for the funding of this research (grant numbers 20012/18333-3, 2013/21224-4, and 2013/21285-3).
Rights and permissions
About this article
Cite this article
Ferraz, M.A., Zabaglia, L.M., Pereira, W.N. et al. Downregulated Expression of E-cadherin and TP53 in Patients with Gastric Diseases: the Involvement of H. pylori Infection and Its Virulence Markers. J Gastrointest Canc 47, 20–26 (2016). https://doi.org/10.1007/s12029-015-9782-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-015-9782-4